BioSpace News Archive

Career Advice

Life Sciences Hiring Increases in June Despite Tight Labor Market

Despite a government report showing that hiring slowed over the month of June, job postings on BioSpace’s life sciences-focused job board saw a marked increase.

July 11, 2023
·
1 min read
·
Rosemary Scott
Business

Novartis Drops Anti-TIGIT Checkpoint Inhibitor Partnership with BeiGene

After paying $300 million upfront to BeiGene for option rights to ociperlimab in December 2021, Novartis has dropped the agreement and given the rights back to the Chinese biotech.

July 11, 2023
·
3 min read
·
Connor Lynch
Drug Development

Viridian Poised to Challenge Horizon in Thyroid Eye Disease

Early-stage data shows that Viridian’s thyroid eye disease candidate induces clinically meaningful improvements in eye protrusion after six weeks of treatment.

July 11, 2023
·
2 min read
·
Tristan Manalac
Business

Abu Dhabi, Dubai Serve as Gateway to International Markets for Biopharma

Burjeel Holdings and BridgeBio Pharma ink partnership deal in rare genetic diseases with a plan to set up headquarters in Abu Dhabi.

July 11, 2023
·
4 min read
·
Lisa Munger
Business

Astellas Licenses 4DMT’s Vector Delivery Platform in Potential $962M Deal

Following its $5.9 billion Iveric Bio buy, Astellas is leaning into the eye disease space with a licensing agreement for 4D Molecular Therapeutics’ proprietary intravitreal AAV delivery system.

July 11, 2023
·
2 min read
·
Tristan Manalac
Policy

EMA Review of Suicide Risk for Ozempic, Saxenda Extended to Other GLP-1 Receptor Agonists

The European Medicines Agency has widened its review of potential suicide risks associated with GLP-1 receptor agonists. The probe, which started July 3, is expected to conclude in November.

July 11, 2023
·
3 min read
·
Tristan Manalac & Lisa Munger
Business

BMS Pays Combined $95M to Evotec, Prothena for Neuro-Focused Options

Bristol Myers Squibb is paying a total of $95 million to the two companies for exclusive global rights to programs developed within long-term partnerships designed to further BMS’ neuro pipeline.

July 11, 2023
·
2 min read
·
Heather McKenzie
Drug Development

ADC Therapeutics Halts Enrollment of Zynlonta Trial After Seven Patient Deaths

Severe respiratory problems killed seven patients and affected five others, though the company said that most of these were likely unrelated to the drug.

July 11, 2023
·
2 min read
·
Maaisha Osman
Deals

7 Life Science IPOs in 2023

A handful of biotechs and pharma companies have posted sizable IPOs in 2023, despite a tight economy. Still, the numbers are way down from last year.

July 11, 2023
·
3 min read
·
Lisa Munger
Business

CVRx to Report Second Quarter 2023 Financial and Operating Results and Host Conference Call on July 25th, 2023

CVRx, Inc. announced that it plans to release second quarter 2023 financial and operating results after market close on Tuesday, July 25th, 2023.

July 11, 2023
·
1 min read